Colorectal cancer offered the earliest window into the trend of increased cancer incidence among those younger than age 50.

Choi Soo-jong and Jin Tae-hyun, the representative lovers of the entertainment industry, are going on a healing trip together ...

also called gastric cancer. was detected at a rate of 1.94 per 100,000. By 2021, that number had risen to 2.97 per 100,000. That’s compared to 2.55 per 100,000 for late-stage cancers detected in ...

1 Current recommended first-line treatment for HER2 positive advanced gastric cancer with PD-L1 CPS ≥1 is trastuzumab in combination with platinum-based chemotherapy (cisplatin plus 5-FU or ...

CARsgen Therapeutics’ CAR-T improved progression-free survival (PFS) compared to approved therapies for patients with advanced stomach cancer in a phase 2 trial. The open-label study assessed ...

Despite Merck’s action, Kelun said in August that its med had shown positive efficacy and acceptable safety in CLDN18.2-expressing gastric cancer during early-stage testing.

The FDA has approved zolbetuximab for the first-line treatment of patients with locally advanced unresectable or metastatic, HER2-negative, CLDN 18.2-positive gastric/GEJ cancer, making it the first ...

This is the first time the FDA has approved a CLDN18.2-directed drug. The agency concurrently approved Roche's Ventana CLDN18 (43-14A) RxDx Assay as a companion diagnostic for identifying gastric ...